| MVCAX | RVACX | MVCAX / RVACX | |
| Total Expense Ratio | 0.97 | 2.07 | 47% |
| Annual Report Gross Expense Ratio | 0.98 | 3.21 | 31% |
| Fund Existence | 25 years | 19 years | - |
| Gain YTD | 10.210 | 5.699 | 179% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.1B | 250M | 6,840% |
| Annual Yield % from dividends | 1.16 | 0.14 | 812% |
| Returns for 1 year | 11.29 | 1.07 | 1,051% |
| Returns for 3 years | 23.67 | -0.13 | -17,703% |
| Returns for 5 years | 14.75 | -17.57 | -84% |
| Returns for 10 years | 87.51 | -24.32 | -360% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBP | 91.63 | 1.62 | +1.80% |
| Virtus LifeSci Biotech Products ETF | |||
| OPTZ | 49.36 | 0.62 | +1.26% |
| Optimize Strategy Index ETF | |||
| EUFN | 39.10 | 0.37 | +0.96% |
| iShares MSCI Europe Financials ETF | |||
| ABLD | 30.24 | -0.02 | -0.05% |
| Abacus FCF Real Assets Leaders ETF | |||
| FGDL | 55.84 | -0.30 | -0.53% |
| Franklin Responsibly Sourced Gold ETF | |||